The cognitive deficits in patients with Alzheimer’s Disease (AD) and Fronto-temporal lobar degeneration (FTLD) are associated with selective loss of neuronal populations in the neocortex, limbic system and subcortical nuclei, in association with progressive accumulation of the cytoskeletal protein Tau [1–7]. This evidence concerns the gene DNM2 and Alzheimer disease.